// App-Quantinova.ai

8506 : Randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small cell lung cancer patients: The NVALT-8 study.

Researchers

Presenter

  • Harry J.M. Groen

Principal Investigators

  • Erik van der Heijden

  • Theo J Klinkenberg

  • Bonne Biesma

  • Joachim Aerts

  • Ad Verhagen

  • Corinne Kloosterziel

  • Hans J.M. Smit

  • Franz Schramel

  • Vincent van der Noort

  • Harm van Tinteren

  • Egbert F. Smit

  • Anne-Marie C. Dingemans

Medical Centers

  • University of Groningen and University Medical Center Groningen, Groningen, Netherlands

  • Radboud University Medical Center, Njmegen, Netherlands

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Department of Pulmonology, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Radboud University Medical Center, Njmegen, Netherlands

  • Isala Hospital, Zwolle, Netherlands

  • Rijnstate Hospital, Arnhem, Netherlands

  • St Antonius Hospital, Nieuwegein, Netherlands

  • Antoni van Leeuwenhoek hospital, Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • VU University Medical Center, Amsterdam, Netherlands

  • Maastricht University Medical Center, Maastricht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • Gemcitabine

  • Pemetrexed

  • Cisplatin

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved